Recruiting Rheumatoid Arthritis Studies in Georgetown
About Rheumatoid Arthritis Clinical Trials in Georgetown
Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.
There are currently 1 rheumatoid arthritis clinical trials recruiting participants in Georgetown, DE. These studies are seeking a combined 4,000 participants. Research is being sponsored by American Gastroenterological Association. Clinical trial participation is free and participants receive study-related medical care at no cost.
Rheumatoid Arthritis Clinical Trials in Georgetown — FAQ
Are there rheumatoid arthritis clinical trials in Georgetown?
Yes, there are 1 rheumatoid arthritis clinical trials currently recruiting in Georgetown, DE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Georgetown?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Georgetown research site will contact you about next steps.
Are clinical trials in Georgetown free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Georgetown studies also compensate for your time and travel.
What rheumatoid arthritis treatments are being tested?
The 1 active trials in Georgetown are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.
Data updated July 13, 2026 from ClinicalTrials.gov